NINE MONTHS RESULTS
Eris Lifesciences Ltd.
BSE
Jun 19, 04:01
1728.75
-49.80 ( -2.80%)
Volume
5043
Prev. Close
1778.55
Open Price
1744.60
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 19, 03:56
1735.80
-44.40 ( -2.49%)
Volume
85607
Prev. Close
1780.20
Open Price
1767.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
1735.80 (60)
You can view the
Nine Months Results
for the last 5 years.
|
ISIN No
|
INE406M01024
|
Market Cap. ( ₹ in Cr. )
|
23641.13
|
P/BV
|
8.53
|
Book Value ( ₹ )
|
203.49
|
|
BSE Code
|
540596
|
52 Week High/Low ( ₹ )
|
1910/987
|
FV/ML
|
1/1
|
P/E(X)
|
67.19
|
|
NSE Code
|
ERISEQ
|
Book Closure
|
13/02/2025
|
EPS ( ₹ )
|
25.83
|
Div Yield (%)
|
0.42
|
(₹ in Crs.)
| Net Sales/Income from operations | 1267.92 | 1122.50 | 998.77 | 916.65 | 835.97 |
| Other Operating Income | 25.06 | 22.91 | 17.38 | 16.94 | 16.02 |
| Total Income From Operations | 1292.98 | 1145.41 | 1016.14 | 933.59 | 851.99 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 58.52 | 78.55 | 89.05 | 87.56 | 77.34 |
| Purchase of Traded Goods | 355.42 | 159.85 | 84.07 | 52.69 | 81.83 |
| Increase/Decrease in Stocks | -39.01 | -23.55 | 14.56 | 9.50 | -10.73 |
| Employees Cost | 280.51 | 252.15 | 191.89 | 169.54 | 160.67 |
| Depreciation | 138.39 | 73.25 | 47.37 | 36.39 | 27.50 |
| Other Expenses | 271.96 | 303.98 | 242.94 | 231.92 | 219.58 |
| Total Expenses | 1065.79 | 844.23 | 669.89 | 587.60 | 556.19 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 227.19 | 301.18 | 346.25 | 345.99 | 295.79 |
| Other Income | 18.76 | 14.43 | 13.00 | 19.94 | 7.25 |
| P/L Before Interest, Excpt. Items & Tax | 245.95 | 315.61 | 359.26 | 365.92 | 303.04 |
| Interest | 167.08 | 28.53 | 17.85 | 2.01 | 0.58 |
| P/L Before Exceptional Items & Tax | 78.87 | 287.09 | 341.40 | 363.91 | 302.46 |
| P/L Before Tax | 78.87 | 287.09 | 341.40 | 363.91 | 302.46 |
| Tax | 31.95 | 26.88 | 31.23 | 33.43 | 21.21 |
| P/L After Tax from Ordinary Activities | 46.92 | 260.20 | 310.17 | 330.48 | 281.26 |
| Net Profit/Loss For the Period | 46.92 | 260.20 | 310.17 | 330.48 | 281.26 |
| | | | | | |
| Equity Share Capital | 13.61 | 13.60 | 13.60 | 13.59 | 13.58 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 3.45 | 19.13 | 22.81 | 24.33 | 20.71 |
| Diluted EPS (Rs.) | 3.44 | 19.11 | 22.80 | 24.32 | 20.69 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 3.45 | 19.13 | 22.81 | 24.33 | 20.71 |
| Diluted EPS (Rs.) | 3.44 | 19.11 | 22.80 | 24.32 | 20.69 |
| | | | | | |
| PBITOE Margin (%) | 17.57 | 26.29 | 34.07 | 37.05 | 34.71 |
| PBTE Margin (%) | 6.09 | 25.06 | 33.59 | 38.97 | 35.50 |
| PBT Margin (%) | 6.09 | 25.06 | 33.59 | 38.97 | 35.50 |
| PAT Margin (%) | 3.62 | 22.71 | 30.52 | 35.39 | 33.01 |